Published in Cytopathology on February 01, 2009
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol (2010) 1.86
Terminology of the BSCC, European Community and the Bethesda system: the boundary between low-grade and high-grade cytology. Cytopathology (2009) 1.39
Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med (2012) 0.92
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines. BMC Cancer (2015) 0.90
HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania. Virol J (2011) 0.89
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment. Int J Cancer (2011) 0.85
Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections. Cancer Med (2015) 0.81
Comparison of the DiagCor GenoFlow Human Papillomavirus Array Test and Roche Linear Array HPV Genotyping Test. Open Virol J (2010) 0.81
Conservative Treatment of Stage IA1 Adenocarcinoma of the Uterine Cervix during Pregnancy: Case Report and Review of the Literature. Case Rep Obstet Gynecol (2014) 0.78
Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma. Ecancermedicalscience (2015) 0.78
Fractal analysis of cervical intraepithelial neoplasia. PLoS One (2014) 0.77
Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review. Onco Targets Ther (2016) 0.75
E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective. Ecancermedicalscience (2015) 0.75
HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions. J Cancer (2016) 0.75
Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet (2006) 5.65
WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet (2001) 5.25
Periradicular infiltration for sciatica: a randomized controlled trial. Spine (Phila Pa 1976) (2001) 3.53
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ (2008) 3.45
Survey of medical training in cytopathology carried out by the journal Cytopathology. Cytopathology (2010) 3.32
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology (2008) 2.67
Sexual functioning among stroke patients and their spouses. Stroke (1999) 2.32
Accuracy of colposcopy-directed punch biopsies: a systematic review and meta-analysis. BJOG (2012) 2.14
Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer (2004) 1.88
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol (2010) 1.86
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev (2009) 1.82
Organic solvents and cancer. Cancer Causes Control (1997) 1.79
Pregnancy outcome after cervical conisation: a retrospective cohort study in the Leuven University Hospital. BJOG (2009) 1.75
The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology (2008) 1.75
Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71
Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol (2005) 1.70
Gene defect in hypodontia: exclusion of EGF, EGFR, and FGF-3 as candidate genes. J Dent Res (1996) 1.66
Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses. Acta Psychiatr Scand (2000) 1.56
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56
Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG (2007) 1.51
Central airways stenosis in school-aged children: differential diagnosis from asthma. Acta Paediatr (2002) 1.50
Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma. Br J Surg (2006) 1.49
Histological recurrence and depth of loop treatment of the cervix in women of reproductive age: incomplete excision versus adverse pregnancy outcome. BJOG (2011) 1.47
Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol (1997) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
The management of failed first trimester pregnancy. Ir Med J (1997) 1.39
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer (2005) 1.37
Comorbidity of hospital-treated psychiatric and physical disorders with special reference to schizophrenia: a 28 year follow-up of the 1966 northern Finland general population birth cohort. Public Health (1998) 1.37
Comparison of GEANT4 very low energy cross section models with experimental data in water. Med Phys (2010) 1.35
Cervical cancer screening: on the way to a shift from cytology to full molecular screening. Ann Oncol (2014) 1.30
Bias against European journals in medical publication Databases. Lancet (1999) 1.28
Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke (1999) 1.28
Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer (2004) 1.27
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res (2001) 1.26
Spontaneous abortions and congenital malformations among the wives of men occupationally exposed to organic solvents. Scand J Work Environ Health (1989) 1.26
TNF signaling via the ligand-receptor pair ectodysplasin and edar controls the function of epithelial signaling centers and is regulated by Wnt and activin during tooth organogenesis. Dev Biol (2001) 1.24
Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study. Int J Cancer (1999) 1.23
Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol (1988) 1.21
Cervical cancer screening programme in Finland. Eur J Cancer (2000) 1.21
Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev (2002) 1.20
Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. Cytopathology (2010) 1.19
Characteristics of incisor-premolar hypodontia in families. J Dent Res (2001) 1.18
Impact of cancer screening on women's health. Int J Gynaecol Obstet (1997) 1.17
European consensus on cancer screening should be applied urgently by health ministers. BMJ (2001) 1.17
Mammographic screening programmes in Europe: organization, coverage and participation. J Med Screen (2012) 1.16
A low voltage diathermy loop for taking cervical biopsies: a qualitative comparison with punch biopsy forceps. Br J Obstet Gynaecol (1986) 1.16
Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study. BJOG (2012) 1.14
Novel mutation of the initiation codon of PAX9 causes oligodontia. J Dent Res (2005) 1.14
Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer (2000) 1.12
Domains and determinants of quality of life after stroke caused by brain infarction. Arch Phys Med Rehabil (2000) 1.12
Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol (2007) 1.12
False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen (2012) 1.11
Tooth morphogenesis and cell differentiation. Curr Opin Cell Biol (1996) 1.11
European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology. Cytopathology (2007) 1.10
Carcinoma of cervix with recent normal Papanicolaou tests. Lancet (1980) 1.10
European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology (2007) 1.09
Trials comparing cytology with human papillomavirus screening. Lancet Oncol (2009) 1.09
Reduced fertility among women exposed to organic solvents. Am J Ind Med (1995) 1.09
Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study. Br J Cancer (2012) 1.07
Paternal occupational lead exposure and spontaneous abortion. Scand J Work Environ Health (1991) 1.07
The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. BJOG (2012) 1.07
The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol (1993) 1.06
Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen (2006) 1.05
Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis (1993) 1.05
Information leaflets, verbal information and women's knowledge of abnormal cervical smears and colposcopy. J Obstet Gynaecol (2003) 1.03
Reduced fertility among female wood workers exposed to formaldehyde. Am J Ind Med (1999) 1.01
Have we dismissed ablative treatment too soon in colposcopy practice? BJOG (2007) 1.01
Ectodysplasin, a protein required for epithelial morphogenesis, is a novel TNF homologue and promotes cell-matrix adhesion. Mech Dev (1999) 1.00
More evidence from a community based series of better outcome in rheumatoid arthritis. Data on the effect of multidisciplinary care on the retention of functional ability. J Rheumatol (1994) 1.00
Does improving communication and information for women increase attendance at colposcopy in an inner city clinic? A randomised controlled trial. Eur J Gynaecol Oncol (2004) 0.99
School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort. Psychol Med (1998) 0.97
Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis. Exp Cell Res (1995) 0.96
Cost effectiveness of periradicular infiltration for sciatica: subgroup analysis of a randomized controlled trial. Spine (Phila Pa 1976) (2001) 0.96
Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer (2003) 0.96
Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination. Clin Exp Immunol (2007) 0.96
Effect of a monoclonal anti-large granular lymphocyte antibody on the human NK activity. J Immunol (1982) 0.96
The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach. Cancer Treat Rev (2006) 0.95